TG Therapeutics, Inc. (LON:0VGI)
London · Delayed Price · Currency is GBP · Price in USD 37.11
+9.04 (32.21%)
At close: Oct 1, 2025
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of 3.66 billion as of October 24, 2025. Its market cap has increased by 52.29% in one year.
Market Cap
3.66B
Enterprise Value
3.66B
Revenue
331.42M
Ranking
n/a
PE Ratio
82.84
Stock Price
37.11
Market Cap Chart
Since January 10, 2012, TG Therapeutics's market cap has increased from 6.62M to 3.66B, an increase of 55,142.90%. That is a compound annual growth rate of 58.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 3.66B | 5.94% |
| Dec 31, 2024 | 3.45B | 81.92% |
| Dec 29, 2023 | 1.90B | 44.26% |
| Dec 30, 2022 | 1.31B | -28.44% |
| Dec 31, 2021 | 1.84B | -62.57% |
| Dec 31, 2020 | 4.91B | 497.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.33B |
| GSK plc | 65.14B |
| Haleon | 31.21B |
| Smith & Nephew | 11.69B |
| ConvaTec Group | 4.97B |
| Hikma Pharmaceuticals | 3.88B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.69B |